Homepage>Company>Media>Pharma News>2018>AB Science provides update on EU marketing authorization application for masitinib in the treatment of amyotrophic lateral sclerosis
AB Science provides update on EU marketing authorization application for masitinib in the treatment of amyotrophic lateral sclerosis